NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM6209166 Query DataSets for GSM6209166
Status Public on Jun 03, 2022
Title SAM17356771
Sample type SRA
 
Source name skin
Organism Mus musculus
Characteristics tissue: skin
cell line: Genetically engineered mouse model (GEMM) tumor
background: C57BL/6
animal id: 2786
biopsy type: second
treatment: vemurafenib
Extracted molecule total RNA
Extraction protocol Total RNA was extracted from cells using the Qiagen All Prep nucleic isolation kit (Qiagen, Inc.; catalog number 80204, Valencia, CA) as per the manufacturer’s protocol, including the on-column DNase digestion. Quality control of samples was done to determine RNA quantity and quality before their processing by RNA sequencing (RNA-seq). The concentration and the integrity of total RNA samples were determined using NanoDrop 8000 (ThermoFisher Scientific, Waltham, MA) and 2200 TapeStation (Agilent Technologies, Santa Clara, CA), respectively. 
One microgram of total RNA was used as an input material for library preparation using TruSeq RNA Sample Preparation Kit v2 (Illumina, San Diego, CA). Library size was confirmed using the 2200 TapeStation and high-sensitivity D1K screen tape (Agilent Technologies, Santa Clara, CA), and their concentration was determined by quantitative PCR-based method using Library quantification kit (Kapa Biosystems, Wilmington, MA). The libraries were multiplexed and then sequenced on HiSeq2500 (Illumina, San Diego, CA) to generate 30 M of single-end 50 base pair reads.
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina HiSeq 2500
 
Description These are biopsy samples derived from the Braf;PTEN melanoma GEMM. An initial biopsy from before treatment with vemurafenib and another biopsy sample after resistance on treatment was collected.
Data processing Sequences were trimmed to 75 bp and filtered for sequencing quality and ribosomal RNA. Reads for which 30% or more of the nucleotides had a Phred quality score of 23 or lower were discarded. The remaining reads were aligned to the mouse genome using the Genomic Short-read Nucleotide Alignment Program (GSNAP), with default settings and the following parameters: -M 2 -n 10 -B 2 -i 1 -N 1 -w 200000 -E 1 --pairmax-rna = 200000 --clip-overlap. Further trimming was not performed. Multimapping reads were discarded. PCR duplications were filtered using PicardTools. We used established gene models from the National Center for Biotechnology Information (NCBI) database and extended those with internal Genomic Mapping and Alignment Program for mRNA and EST sequences (GMAP) alignments for additional genes not in NCBI database.
Assembly: mm9
Supplementary files format and content: Raw counts are provided in a gene x sample format. Entrez gene ids are given.
 
Submission date Jun 01, 2022
Last update date Jun 03, 2022
Contact name Dorothee Nickles
E-mail(s) nicklesd@gene.com
Organization name Genentech
Street address 1 DNA Way
City South San Francisco
State/province CA
ZIP/Postal code 94080
Country USA
 
Platform ID GPL17021
Series (2)
GSE205251 Melanoma GEMM Tumors, untreated or vemurafenib treated [bulk RNA-seq]
GSE205294 Melanoma GEMM Tumors, untreated or vemurafenib treated
Relations
BioSample SAMN28811430
SRA SRX15555189

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap